Mirum Pharmaceuticals, Inc.

MIRM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$88-$163-$136-$84
Dep. & Amort.$24$11$4$1
Deferred Tax$0$0-$7$1
Stock-Based Comp.$48$35$27$23
Change in WC$23-$23-$21$17
Other Non-Cash$4$69$12-$90
Operating Cash Flow$10-$71-$120-$133
Investing Activities
PP&E Inv.-$1-$0-$0-$19
Net Acquisitions$0-$213-$8-$19
Inv. Purchases-$89-$27-$132-$198
Inv. Sales/Matur.$20$153$140$158
Other Inv. Act.-$20-$20$8$127
Investing Cash Flow-$90-$107$8$49
Financing Activities
Debt Repay.$0$305$0$0
Stock Issued$18$217$107$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$185$2$67
Financing Cash Flow$18$337$109$73
Forex Effect-$1-$0$0-$0
Net Chg. in Cash-$63$158-$3-$11
Supplemental Information
Beg. Cash$286$128$131$142
End Cash$223$286$128$131
Free Cash Flow$9-$91-$120-$152